Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-08-01-2012
Volume0
Issue 0

Pharmaceutical Executive Digital Edition - August 2012

Piramal Pivots for Growth

Articles in this issue
Pharmaceutical Executive Digital Edition - August 2012
i28-785323-1408595897784.jpg
Country Report: Mexico
Sunny Outlook for Biopharm 2020?
Sunny Outlook for Biopharm 2020?
i1-784895-1408601437617.jpg
The Phrase that Plays
Planning that Thousand Year Future
Planning that Thousand Year Future

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Matt Riordan
August 27th 2025

Bridging the Gap Between Innovation and Access: Q&A with Matt Riordan

Mike Hollan
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 27th 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
MannKind Expands Cardiometabolic and Lung Portfolio with $360 Million Acquisition of scPharmaceuticals
August 27th 2025

MannKind Expands Cardiometabolic and Lung Portfolio with $360 Million Acquisition of scPharmaceuticals

Don Tracy, Associate Editor
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 27th 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
Stock.adobe.com
August 27th 2025

U.S. CDC Elects mRNA Vaccine Critic to Lead Covid-19 Immunization Workgroup

Nicholas Jacobus
FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events
August 27th 2025

FDA Expands Indication for Amgen’s Repatha to Include Adults with High LDL-Cholesterol at Increased Risk of Major Cardiovascular Events

Don Tracy, Associate Editor